FBTCX Mutual Fund (Fidelity Advisor Biotechnology Fund Class C) is managed by Fidelity Investments (US) with $60.2M in net assets. FBTCX expense ratio is 1.71%, holding 92 positions across sectors including Health Care, Financials, Unknown. Inception date: 2000-12-27.

FBTCX performance shows a YTD return of 5.37%. The 1-year return is 57.37% and the 5-year return is 13.56%. FBTCX dividend yield stands at 1.28%, paid annually.

FBTCX top holdings include Abbvie Inc (16.6%), Gilead Sciences Inc (6.6%), Alnylam Pharmace (5.0%), Ascendis Pharma As Adr (4.5%), Cogent Biosciences Inc (3.8%). View all FBTCX holdings, sector breakdown, or dividend history.

FBTCX can be compared against other funds using the overlap calculator or side-by-side comparison tool. FBTCX alternatives are available via the screener, along with tax-loss harvesting opportunities.